Coming up #AACR2024 today 1:30 PM - 5:00 PM: “Identifying gut microbial determinants of clonal hematopoiesis of indeterminate potential (CHIP) in immunotherapy-treated melanoma patients” co-authored by TeamLab member Dr. K. Takahashi MD Anderson Cancer Center #RadicalCollaboration

Excited to see Break Through Cancer TeamLab member Laura DeLong Wood Dr. Laura D. Wood's research shared at #AACR2024 #RadicalCollaboration

Thrilled to announce our new multi-year partnership with ALK Positive, a foundation funded by patients with ALK-positive lung cancer and their families. #RadicalCollaboration Learn more about the partnership here wkbn.com/business/press…

We are so excited to be partnering with ALK Positive and to have Jesse Boehm join ALKtALK live at #ASCO24

ALKtALK replay available featuring, Jesse Boehm, PhD, of Break Through Cancer (BTC). We highlight our ambitious $2m partnership w BTC aiming to cure ALK+ cancer. We also kicked off ALK Positive Awareness Month & our #CollabForACure campaign. Watch via👉youtu.be/Yx2al5xUvxk #APAM

The Break Through Cancer #ClonalHematopoiesis team after productive day of discussions and planning. 💪🏼

Who doesn't love early morning #radicalcollaboration and huge smiles.

Congratulations to our Chief Scientific Officer @JesseBoehm, and TeamLab member Rameen Beroukhim on their new paper in Nature Communications highlighting the impact of ancestry on CRISPR experiments is crucial for ensuring diversity in scientific research. This sets the stage for many

It’s 95 degrees outside but feels like Christmas is here early! 🎄 Can’t wait to “open sesame” our brand new 10x Genomics Xenium. Linghua Wang, MD, PhD

We are excited about the perspectives of @Christine_Lovly, JessicaJLinMD, Justin Gainor, and Vincent Lam calling for a fundamental shift in tackling lung cancer by targeting drug-resistant residual disease. Proud to support you and the team to make these concepts a reality.

What an incredible moment that must have been! We are thrilled to see John Carpten, a member of our Scientific Advisory Board, receive such a heartfelt honor at #BiCconf24. Congratulations, John! BlackinCancer

We are proud to celebrate our Scientific Portfolio Manager, Dr. John Okello John BA Okello, for his recent commentary in Pediatric Research, "Integrative Metabolomics and the Distinctive Signature Profiles in Patients with Tetralogy of Fallot." Read more here nature.com/articles/s4139…

We are excited to celebrate Dr. Elana J Fertig Dr. Elana J. Fertig’s new role as the incoming Director Institute for Genome Sciences @UMmedschoolthe. Dr. Fertig is a core member of our Break Through Cancer data science community. We can’t wait to see her radically collaborative spirit in action!

We are delighted to celebrate Dr. Laurie Glimcher Laurie Glimcher MD , a valued member of our board, for her remarkable tenure as President and CEO, now President Emerita, of Dana-Farber. We also look forward to continued collaboration under the new leadership of Dr. Benjamin Ebert, a